The 24-month outcomes of intravitreal aflibercept combined with photodynamic therapy for polypoidal choroidal vasculopathy.
Shunichiro NakaiWataru MatsumiyaOtsuka KeikoAkiko MikiMakoto NakamuraShigeru HondaPublished in: Japanese journal of ophthalmology (2018)
In this study, combination therapy of IVA and vPDT yielded visual and anatomical improvements in treatment-naïve PCV patients over a 24-month follow-up period.
Keyphrases
- combination therapy
- age related macular degeneration
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- optical coherence tomography
- type diabetes
- metabolic syndrome
- patient reported outcomes
- drug delivery
- insulin resistance
- skeletal muscle
- adipose tissue
- weight loss